Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
14 studies found for:    parkinson's disease PARS
Show Display Options
Rank Status Study
1 Recruiting Using Parkinson's Disease to Study the Role of the Substantia Nigra Pars Reticulata
Condition: Parkinson's Disease
2 Active, not recruiting A Study Evaluating Potential Screening Tools for Detecting Parkinson Disease
Condition: Parkinson Disease
Interventions: Procedure: [123I]β-CIT and SPECT imaging;   Drug: [123I]β-CIT
3 Recruiting Combined Stimulation of STN and SNr for Resistant Freezing of Gait in Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Procedure: [standard STN];   Procedure: [STN+SNr]
4 Unknown  Temporal Expectations in Parkinson's Disease
Conditions: Parkinsons Disease;   Healthy
5 Enrolling by invitation Cont. of a Study to Evaluate Implanting Peripheral Nerve Grafts Into Subjects With Parkinson's Disease (PD) During DBS
Condition: Parkinson's Disease
Intervention: Procedure: Autologous Peripheral Nerve Graft
6 Completed Observational Study of Heart Valve Disease in Patients With Parkinson's Disease Treated With Pergolide
Conditions: Parkinson's Disease;   Pergolide
Intervention: Procedure: echocardiography
7 Completed Combined STN/SNr-DBS for the Treatment of Refractory Gait Disorders in Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Device: deep brain stimulation (ACTIVA PC, Medtronic)
8 Completed EEG and Pharmacological Exploration of Executive Dysfunctions Induced by STN-DBS in PD
Condition: Parkinson Disease
Interventions: Device: Clonidine (Catapressan);   Device: Placebo 90 minutes before EEG
9 Completed Efficacy and Safety of the Iron Chelator Deferiprone in Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: deferiprone;   Drug: placebo
10 Recruiting Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Parkinson's Disease
Conditions: Parkinson Disease;   Parkinsons Disease With Dementia
Interventions: Drug: Placebo Oral Capsule;   Drug: Nilotinib 150mg oral capsule [Tasigna];   Drug: Nilotinib 300mg oral capsule [Tasigna]
11 Recruiting Efficacy of a Non-invasive Device for Alleviation of Parkinson's Disease Symptoms
Condition: Parkinson's Disease
Interventions: Device: Electro-stimulation;   Other: Placebo
12 Terminated Functional Characterization of Parkin + Patients
Condition: Parkinson's Disease
13 Completed Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Conditions: Dyskinesia;   Levodopa Induced Dyskinesia;   Parkinson's Disease
Intervention: Drug: ADS-5102 (extended release amantadine HCl)
14 Recruiting Deep Brain Stimulation in Treatment Resistant Schizophrenia
Condition: Treatment-resistant Schizophrenia
Intervention: Device: Medtronic Activa Deep Brain Stimulation System

Study has passed its completion date and status has not been verified in more than two years.